Characterization of pazopanib resistance in renal cell carcinoma cell lines

被引：1
|
作者：
Vynnytska-Myronovska, Bozhena [1 ]
Heinzelmann, Joana [1 ]
Hoelters, Sebastian [1 ]
Stoeckle, Michael [1 ]
Junker, Kerstin [1 ]
机构：
[1] Saarland Univ, Homburg, Germany
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2840
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2840
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Reintroducing Pazopanib Reverses the Primary Resistance of Nivolumab in a Patient With Metastatic Clear-cell Renal Cell Carcinoma
    Su, Harvey Yu-Li
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : 114 - 116
  • [22] Characterization and modulation of transitional cell carcinoma cell lines with acquired multidrug resistance
    Yu, DS
    Chang, SY
    Ma, CP
    BRITISH JOURNAL OF UROLOGY, 1998, 81 (02): : 234 - 240
  • [23] Systemic sarcoidosis during pazopanib treatment for clear cell renal cell carcinoma
    Vaccaro, Mario
    Borgia, Francesco
    Lentini, Maria
    Gaeta, Michele
    Marafioti, Ilenia
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2023, 89 (03): : 444 - 446
  • [24] Characterization of renal tumor initiating cells in human renal carcinoma cell lines
    Wang, Lin
    Park, Paul
    Zhang, Huina
    La Marca, Frank
    Lin, Chia-Ying
    CANCER RESEARCH, 2011, 71
  • [25] Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Cella, David
    Reeves, James
    Hawkins, Robert
    Guo, Jun
    Nathan, Paul
    Staehler, Michael
    de Souza, Paul
    Merchan, Jaime R.
    Boleti, Ekaterini
    Fife, Kate
    Jin, Jie
    Jones, Robert
    Uemura, Hirotsugu
    De Giorgi, Ugo
    Harmenberg, Ulrika
    Wang, Jinwan
    Sternberg, Cora N.
    Deen, Keith
    McCann, Lauren
    Hackshaw, Michelle D.
    Crescenzo, Rocco
    Pandite, Lini N.
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 722 - 731
  • [26] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?
    Ronald M. Bukowski
    Current Oncology Reports, 2010, 12 : 77 - 79
  • [27] Pazopanib-induced chylothorax in a patient with renal cell carcinoma
    Koylu, Bahadir
    Tekin, Fatih
    Aktas, Burak Yasin
    Kilickap, Saadettin
    Koksal, Deniz
    ANTI-CANCER DRUGS, 2022, 33 (01) : E555 - E557
  • [28] Efficacy and safety of Pazopanib in the treatment of metastatic renal cell carcinoma
    Marmesat Rodas, B.
    Marquez Fernandez, E.
    Quesada Sanz, M. P.
    Guerra Estevez, D.
    Villanueva Jimenez, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 572 - 572
  • [29] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?
    Bukowski, Ronald M.
    CURRENT ONCOLOGY REPORTS, 2010, 12 (02) : 77 - 79
  • [30] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
    Hutson, Thomas E.
    Davis, Ian D.
    Machiels, Jean-Pascal H.
    De Souza, Paul L.
    Rottey, Sylvie
    Hong, Bao-fa
    Epstein, Richard J.
    Baker, Katherine L.
    McCann, Lauren
    Crofts, Theresa
    Pandite, Lini
    Figlin, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 475 - 480
12345